Autism Spectrum Disorder Treatment Market Size to Surpass USD 3.42 billion by 2030, exhibiting a CAGR of 7.9%
As per the report by Fortune Business Insights, the global Autism Spectrum Disorder Treatment Market size is projected to reach USD 3.42 billion by 2030, at a CAGR of 7.9% during the forecast period
Pune, India, June 21, 2023 (GLOBE NEWSWIRE) — According to Fortune Business Insights, global Autism Spectrum Disorder Treatment Market size was valued at USD 1.93 billion in 2022 and is projected to grow from USD 2.01 billion in 2023 to USD 3.42 billion by 2030, exhibiting a CAGR of 7.9% during the forecast period. The rising occurrence of ASD across the world, pooled with growing consciousness regarding the ailment and the accessible choices for numerous treatment options for several ASD diseases are the factors aiding market expansion. This information is provided by Fortune Business Insights™, in its report, titled, “Autism Spectrum Disorder Treatment Market, 2023-2030.”
Key Industry Development
July 2021: The Saskatchewan Government declared that families with children detected with Autism Spectrum Disorder (ASD) will get help from extended funding. From 27th July 2021, Autism Individualized Finance was made accessible for children of age 11. Children born on or before March 31, 2021, were qualified to make an application for the final payment.
Request a Free Sample PDF: https://www.fortunebusinessinsights.com/enquiry/sample/autism-spectrum-disorder-therapeutics-market-101207
- Among the drug therapy segment, the stimulants segment is expected to lead this market during the forecast period.
- Otsuka Holdings Co. Ltd., and Janssen Pharmaceuticals, Inc. are some of the key players in the global market.
- North America dominated the market in terms of share in 2022.
- The growing patient pool, increased incidence of the condition, and increased initiatives for the launches of effective therapeutics are expected to drive the adoption.
Discover the Leading Players Featured in the Report:
Leading Players in Autism Spectrum Disorder Treatment Market are, Curemark, LLC (U.S.), Alembic Pharmaceuticals Limited (India), Yamo Pharmaceuticals (U.S.), PaxMedica (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Aurobindo Pharma Ltd. (India), Otsuka Holdings Co. Ltd. (Japan), Janssen Pharmaceuticals, Inc. (New Jersey), Teva Pharmaceutical Industries Ltd. (Israel), H. Lundbeck A/S (Denmark)
|Forecast Period||2023 to 2030|
|Forecast Period 2023 to 2030 CAGR||7.9%|
|2030 Value Projection||USD 3.42 Billion|
|Market Size in 2023||USD 2.01 Billion|
|Historical Data for||2019 to 2021|
|No. of Pages||162|
Speak to Analyst: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/autism-spectrum-disorder-therapeutics-market-101207
Driving and Restraints:
Growing Occurrence of Autism Spectrum Conditions to Boost Market Growth
The rising occurrence of autism spectrum disorders (ASD) is positively influencing the autism spectrum disorder treatment market growth across the world, which has resulted in a surging demand for clinical research for efficient autism spectrum disorder treatment. This can enhance patient outcomes and improve precision for the treatment of these ailments. For example, as per an assembled report on Global Autism Rates by Global Health Data Exchange, nations such as France and Portugal have the least autism rate of 0.69% and 0.71%, respectively.
On the other hand, the lack of approved drugs to treat autism and its other important symptoms will hinder market expansion in the upcoming years.
We present our reports that are directed with a comprehensive review approach that primarily focuses on offering accurate information. Our professionals have applied a data navigation technique that further aids us to present reliable predictions and examine the global market dynamics perfectly. Further, our analysts have gained admittance to various international as well as regional funded records for presenting the updated information so that the entrepreneurs and shareholders capitalize only in the operative areas.
Stimulants Segment to Lead As They Help in Maintaining Certain Symptoms Of Autism
Based on drug therapy, the global market is segmented into antipsychotic drugs, SSRIs/antidepressants, stimulants, sleep medications, and others. The stimulants segment dominated the market in 2022 as they substantially contribute to the maintenance of certain symptoms associated with autism.
Autistic Disorder Segment to Dominate Backed by Rising Prevalence of Disease
As per disease, the market is split into autistic disorder, Asperger syndrome, pervasive developmental disorder, and others. The autistic disorder segment captured a substantial market share in 2022 owing to the high prevalence of this disease.
Adult Segment to Hold Major Share Stoked by Availability of Cost-Effective Therapies
According to the patient age group, the global market can be segmented into children and adults. The adult segment accounted for a significant autism spectrum disorder treatment market share in 2022 due to the rising number of service providers offering a wide range of cost-effective therapies. Moreover, the rising prevalence of autism in adult patients is attributed to segment expansion.
Quick Buy – Autism Spectrum Disorder Treatment Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/101207
Hospital Pharmacies Segment to Capture Dominant Share As Therapeutics Can Be Prescribed by Medical Professionals
Speaking of distribution channels, the global market can be segmented into hospital pharmacies, drug stores & retail pharmacies, and online pharmacies. The hospital pharmacies segment led the market in 2022 as therapeutics can only be prescribed after thorough examinations by trained medical professionals at hospitals.
Regionally, the market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
North America to Account for Largest Share Due to Rising Adoption of Therapies for ASD Treatment
North America dominated the global market in 2022 owing to the rising occurrence of autism spectrum disorder across the U.S., and the growing adoption of therapies for its treatment. For instance, as per the John Hopkins report published in 2020, the prevalence of autism in the U.S. has tripled since 2000 from 0.67% to 1.85%.
The Europe market is slated to record significant expansion backed by rising awareness regarding ASD, improved diagnostic criteria, and higher product sales.
Asia Pacific market is slated to grow rapidly stoked by surging demand for effective treatment options and the development of healthcare infrastructure is aiding regional market proliferation.
Government Announcements Regarding Public Welfare to Make Positive Changes in Market
Governments of several nations are incessantly trying to present new schemes for the welfare of their population. They either raise funding for treatment purposes or provide subsidies. This benefits the common public as they are unable to pay for expensive treatments.
Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/autism-spectrum-disorder-therapeutics-market-101207
How big is the Autism Spectrum Disorder Treatment Market?
The Autism Spectrum Disorder Treatment Market size was USD 2.01 Billion in 2023.
How fast is the Autism Spectrum Disorder Treatment Market growing?
The Autism Spectrum Disorder Treatment Market will exhibit a CAGR of 7.9% during the forecast period, 2023-2030
Diabetes Treatment Devices Market Share, Size, Trends and Forecast 2023-2030
Next-generation Sequencing Market Size, Share, Trends, Growth | Global Forecast Report 2029
Aesthetic Implants Market Size, Share, Trends, Growth 2023-2030
Hormonal Contraceptives Market Trends, Growth 2023-2030
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
Fortune Business Insights Pvt. Ltd.
9th Floor, Icon Tower, Baner
US:+1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: [email protected]
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. AfternoonHeadlines.com takes no editorial responsibility for the same.